Status:

COMPLETED

Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments

Lead Sponsor:

Université de Sherbrooke

Collaborating Sponsors:

Canadian International Development Agency

Conditions:

Bacterial Vaginosis

Candidiasis

Eligibility:

FEMALE

11+ years

Phase:

PHASE3

Brief Summary

This randomised controlled trial aimed to verify whether directly observed single dose treatment (with tinidazole+fluconazole) would be as effective as the longer standard treatments (metronidazole fo...

Detailed Description

Abstract Objective: Evaluate whether single-dose treatments are as effective as standard therapy in the syndromic management of vaginal discharge. Methods: A randomized controlled effectiveness trial...

Eligibility Criteria

Inclusion

  • women consulting for vaginal discharge
  • local resident
  • willingness and ability to consent

Exclusion

  • sex worker consulting for active screening
  • main complaint of lower abdominal pain
  • allergy to one of the study drugs

Key Trial Info

Start Date :

January 1 2004

Trial Type :

INTERVENTIONAL

End Date :

May 1 2005

Estimated Enrollment :

1524 Patients enrolled

Trial Details

Trial ID

NCT00313131

Start Date

January 1 2004

End Date

May 1 2005

Last Update

April 11 2006

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Adabraka Polyclinic

Accra, Ghana

2

Suntreso Polyclinc

Kumasi, Ghana

3

Centre de Santé Carrière

Conakry, Guinea

4

Centre de Santé Madina

Conakry, Guinea

Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments | DecenTrialz